Avraham Gabay Oramed Pharmaceuticals Inc. (ORMP) insider trading activity
Avraham Gabay is Chief Financial Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 0 shares of ORMP, which is worth approximately $0. The most recent transaction as insider was on Jun 21, 2024, when has been sold 140,040 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
n/a
3M change
n/a
12M change
Total Value Held
$0
AG
Avraham Gabay
Chief Financial Officer
Jerusalem, L3